Sano Chemicals
Sano Chemicals, founded in 2012 in Bryan, Texas, develops novel antibiotics and antifungal treatments, including the lead compounds Occidiofungin and Mutacin, for drug-resistant infections.
Company History
Sano Chemicals was founded in 2012 in Bryan, Texas near Texas A&M University. The company has established itself as a significant player in the pharmaceutical industry by focusing on the development of novel antibiotics and treatments for drug-resistant infections. Sano Chemicals has received recognition and awards through the Texas New Venture Competition and MassChallenge, contributing to its growth and visibility in the industry.
Innovative Therapies
Sano Chemicals is at the forefront of developing new treatments for antibiotic-resistant pathogens, including MRSA. The company’s lead compound, Occidiofungin, is a first-in-class antifungal treatment currently under investigation for treating recurrent vulvovaginal candidiasis, systemic fungal infections, and dermal and mucosal applications. Additionally, Sano Chemicals is developing Mutacin, a first-in-class therapeutic for treating serious Gram-positive infections that has shown superiority to vancomycin in preclinical models.
Clinical Trials and Research
Sano Chemicals has made significant strides in clinical research. The FDA has approved an investigational new drug application (INDA) for Occidiofungin, allowing Phase 1 clinical trials to commence. The company also received a research award from the National Institute of Allergy and Infectious Diseases (NIAID-NIH) for the preclinical development of OCF001, aimed at treating yeast infections.
Funding and Patents
Sano Chemicals has successfully raised $7 million in funding and holds 9 patents, underscoring its commitment to advancing innovative healthcare solutions. The company has developed 7 indications currently under development, showcasing the breadth of its research initiatives. Sano Chemicals' achievements have been recognized with prize money from competitions such as the Texas New Venture Competition.
Collaborations and Partnerships
Sano Chemicals has entered a license agreement with Indigo Ag to develop antifungal technology for agricultural products. This collaboration highlights the company’s innovative approach by extending its antifungal treatments beyond traditional medical applications into the agricultural sector. Additionally, Sano Chemicals was selected to be part of the MassChallenge cohort, further emphasizing its status as an emerging leader in pharmaceutical research and development.